These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Study of the statistical characteristics of the USP XXI content uniformity sampling plan for tablets]. Tao QF; Zhong DF; Luo X; Wang X Yao Xue Xue Bao; 1987 Mar; 22(3):212-6. PubMed ID: 3661209 [No Abstract] [Full Text] [Related]
6. Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010). Schepers U; Wätzig H J Pharm Biomed Anal; 2006 Apr; 41(1):290-2. PubMed ID: 16338114 [TBL] [Abstract][Full Text] [Related]
7. Content uniformity acceptance limit for a validation batch--suppositories, transdermal systems, and inhalations. Senderak ET Drug Dev Ind Pharm; 2009 Jun; 35(6):735-7. PubMed ID: 19514989 [TBL] [Abstract][Full Text] [Related]
8. Statistical analysis of the USP 18 content uniformity sampling plan for tablets. Langenbucher F Pharm Acta Helv; 1972; 47(2):142-52. PubMed ID: 5024143 [No Abstract] [Full Text] [Related]
9. Content uniformity and assay requirements in current regulations. Bánfai B; Ganzler K; Kemény S J Chromatogr A; 2007 Jul; 1156(1-2):206-12. PubMed ID: 17109871 [TBL] [Abstract][Full Text] [Related]
11. Panel discussion: proposed changes in the USP--microbiological aspects. I. Proposed changes in the USP sterility test. Clapp FL Bull Parenter Drug Assoc; 1969; 23(6):252-4. PubMed ID: 4901566 [No Abstract] [Full Text] [Related]
12. USP standards. Banes D Am J Hosp Pharm; 1976 Dec; 33(12):1245. PubMed ID: 998641 [No Abstract] [Full Text] [Related]
13. An epic decision by USP. Provost GP J Am Pharm Assoc; 1977 Sep; 17(9):547. PubMed ID: 893923 [No Abstract] [Full Text] [Related]
14. Relationship of USP-NF to NDA and ANDA "Standards". Belson JJ Am J Hosp Pharm; 1982 May; 39(5):869-70. PubMed ID: 7081269 [No Abstract] [Full Text] [Related]
15. USP and the Drug Regulation Reform Act. Heller WM J Parenter Drug Assoc; 1979; 33(2):55-60. PubMed ID: 255147 [No Abstract] [Full Text] [Related]
16. Parametric two-stage sequential quality assurance test of dose content uniformity. Tsong Y; Shen M J Biopharm Stat; 2007; 17(1):143-57. PubMed ID: 17219760 [TBL] [Abstract][Full Text] [Related]
17. USP standards for dissolution and bioavailability. Grady LT Am J Hosp Pharm; 1982 Sep; 39(9):1546-8. PubMed ID: 7137198 [No Abstract] [Full Text] [Related]
18. Voluntary standards--the USP and the PDA. Schmitz AJ J Parenter Drug Assoc; 1980; 34(6):425-6. PubMed ID: 6906364 [No Abstract] [Full Text] [Related]
19. General requirements for parenteral pharmaceuticals for the 21st USP revision--for the 21st Century. Barnstein CH J Parenter Drug Assoc; 1979; 33(5):287-9. PubMed ID: 259651 [No Abstract] [Full Text] [Related]